» Articles » PMID: 2847730

Forskolin and Prostacyclin Inhibit Fluoride Induced Platelet Activation and Protein Kinase C Dependent Responses

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1988 Nov 15
PMID 2847730
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet activation (cytosolic [Ca2+] increase, aggregation and ATP secretion) was induced with A1F-4. This agent presumably interacts with a G protein which appears to mediate the coupling of the receptors for Ca mobilizing hormones and phospholipase C. All the A1F-4 evoked responses were inhibited by treatment with forskolin or prostacyclin, agents known to increase cellular cAMP. Thus the G protein-phospholipase C system appears to be the site of cAMP inhibition. Unexpectedly forskolin and prostacyclin also inhibited secretion and aggregation induced by the activators of protein kinase C, diglyceride and phorbol ester, suggesting that cAMP can also inhibit directly the protein kinase C dependent responses.

Citing Articles

Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Huttinger Z, Milks M, Nickoli M, Aurand W, Long L, Wheeler D Am J Pathol. 2012; 181(1):322-33.

PMID: 22613024 PMC: 3388153. DOI: 10.1016/j.ajpath.2012.03.024.


Arachidonic acid activates a proton conductance pathway and the Na+/H+ exchanger in platelets.

Cavallini L, Coassin M, Borean A, Alexandre A Biochem J. 1996; 319 ( Pt 2):567-74.

PMID: 8912696 PMC: 1217805. DOI: 10.1042/bj3190567.


Ca2+ influx in platelets: activation by thrombin and by the depletion of the stores. Effect of cyclic nucleotides.

Doni M, Cavallini L, Alexandre A Biochem J. 1994; 303 ( Pt 2):599-605.

PMID: 7980423 PMC: 1137369. DOI: 10.1042/bj3030599.


Two classes of agonist-sensitive Ca2+ stores in platelets, as identified by their differential sensitivity to 2,5-di-(tert-butyl)-1,4-benzohydroquinone and thapsigargin.

Cavallini L, Coassin M, Alexandre A Biochem J. 1995; 310 ( Pt 2):449-52.

PMID: 7654182 PMC: 1135916. DOI: 10.1042/bj3100449.


S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.

Heller R, Bussolino F, Calvino R, Ghigo D, Alessio P, Todde R Agents Actions. 1993; 40(3-4):157-65.

PMID: 7517616 DOI: 10.1007/BF01984055.